Cargando…
Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends
Epigenetic drug discovery field has evidenced significant advancement in the recent times. A plethora of small molecule inhibitors have progressed to clinical stage investigations and are being explored exhaustively to ascertain conclusive benefits in diverse malignancies. Literature precedents indi...
Autores principales: | Nepali, Kunal, Liou, Jing-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040241/ https://www.ncbi.nlm.nih.gov/pubmed/33840388 http://dx.doi.org/10.1186/s12929-021-00721-x |
Ejemplares similares
-
Glioblastoma: Current
Status, Emerging Targets, and
Recent Advances
por: Thakur, Amandeep, et al.
Publicado: (2022) -
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal
por: Nepali, Kunal, et al.
Publicado: (2022) -
Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease
por: Athar, Teeba, et al.
Publicado: (2021) -
Novel Gels: An Emerging Approach for Delivering of Therapeutic Molecules and Recent Trends
por: Sastri, Trideva K., et al.
Publicado: (2022) -
Recent advances in epigenetic anticancer therapeutics and future perspectives
por: Ren, Liwen, et al.
Publicado: (2023)